(Q44582977)

4 December 2017

title

Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation (English)

1 reference

4 December 2017

1 reference

1 reference

10

1 reference

4 December 2017

Jia-Hong Lu

1

1 reference

4 December 2017

Mustafa Taleb Ardah

2

1 reference

4 December 2017

Siva Sundara Kumar Durairajan

3

1 reference

4 December 2017

Liang-Feng Liu

4

1 reference

4 December 2017

Li-Xia Xie

5

1 reference

4 December 2017

Wang-Fun David Fong

6

1 reference

4 December 2017

Mohamed Y Hasan

7

1 reference

4 December 2017

Jian-Dong Huang

8

1 reference

4 December 2017

Omar M A El-Agnaf

9

1 reference

4 December 2017

language of work or name

1 reference

26 January 2011

1 reference

4 December 2017

1 reference

4 December 2017

volume

12

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

615-624

1 reference

Toxic proteins in neurodegenerative disease

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Amyloid fibrillogenesis: themes and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

The biochemistry of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Formation of toxic oligomeric alpha-synuclein species in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Baicalein and 12/15-lipoxygenase in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Iron-binding and anti-Fenton properties of baicalein and baicalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

CHIP targets toxic alpha-Synuclein oligomers for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Monoclonal antibodies that target pathological assemblies of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Amyloid diseases: abnormal protein aggregation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Manipulating the amyloid-beta aggregation pathway with chemical chaperones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Molecular mechanisms underlying the flavonoid-induced inhibition of alpha-synuclein fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Sustained neuroprotection and facilitation of behavioral recovery by the Ginkgo biloba extract, EGb 761, after transient forebrain ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Effects of baicalein on beta-amyloid peptide-(25-35)-induced amnesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

Genetics of Parkinson's disease and biochemical studies of implicated gene products: Commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201000604

21 January 2018

Identifiers

DOI

10.1002/CBIC.201000604

1 reference

4 December 2017

1 reference